Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.41 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.41 |
| ▸ | CHRNA10 | Q9GZZ6 | 2/20 | 0.41 |
| ▸ | CHRNA9 | Q9UGM1 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23244045 | 1.00 | HSP90AA1 (0.42) | HSP90AA1MAPK1SMN1; SMN2KDM4ECHRNA7 | |
| SCHEMBL21596560 | 0.84 | AKR1B10 (0.40) | KDM4ECHRNA7CHRNB4CHRNA3CHRNA10 | |
| 4-Vinylphenol SCHEMBL29266700 | 0.82 | ALDH1A1 (0.39) | SMN1; SMN2KDM4ECHRNA7CHRNB4CHRNA3 | |
| SCHEMBL17968578 | 0.81 | TRPM8 (0.45) | SMN1; SMN2KDM4ETRPM8 | |
| SCHEMBL17968577 | 0.81 | CHRNB4 (0.39) | KDM4ECHRNA7CHRNB4CHRNA3CHRNA10 | |
| SCHEMBL1006660 | 0.80 | IDO1 (0.43) | HSP90AA1MAPK1SMN1; SMN2KDM4ECHRNA7 | |
| SCHEMBL10299699 | 0.80 | HCAR2 (0.47) | MAPK1KDM4ETRPM8 | |
| SCHEMBL17968585 | 0.79 | NFE2L2 (0.44) | SMN1; SMN2KDM4ETRPM8 | |
| SCHEMBL21596594 | 0.79 | TRPM8 (0.50) | SMN1; SMN2KDM4ETRPM8 | |
| SCHEMBL23244052 | 0.79 | TRPM8 (0.50) | SMN1; SMN2KDM4ETRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111936457-B | Enol ether pro-fragrances | 弗门尼舍有限公司 | 2025-02-25 | — | — | CN | claimed |
| US-20230257678-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2023-08-17 | — | — | US | claimed |
| EP-3746420-B1 | ENOL ETHER PROPERFUME | FIRMENICH & CIE (CH) | 2023-08-16 | — | — | EP | claimed |
| US-20210115354-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2021-04-22 | — | — | US | claimed |
| CN-111936457-A | Enol ether pro-fragrances | 弗门尼舍有限公司 | 2020-11-13 | — | — | CN | claimed |
| EP-1853327-B1 | MEDICAL DEVICES HAVING POLYMERIC REGIONS WITH COPOLYMERS CONTAINING HYDROCARBON AND HETEROATOM-CONTAINING MONOMERIC SPECIES | BOSTON SCIENT LTD (BB) | 2012-11-07 | — | — | EP | claimed |
| EP-1853327-A2 | MEDICAL DEVICES HAVING POLYMERIC REGIONS WITH COPOLYMERS CONTAINING HYDROCARBON AND HETEROATOM-CONTAINING MONOMERIC SPECIES | Boston Scientific Limited (BB) | 2007-11-14 | — | — | EP | claimed |
| WO-2006083628-A2 | MEDICAL DEVICES HAVING POLYMERIC REGIONS WITH COPOLYMERS CONTAINING HYDROCARBON AND HETEROATOM-CONTAINING MONOMERIC SPECIES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-08-10 | — | — | WO | claimed |
| US-20060171981-A1 | Medical devices having polymeric regions with copolymers containing hydrocarbon and heteroatom-containing monomeric species | BOSTON SCIENTIFIC SCIMED, INC. | 2006-08-03 | — | — | US | claimed |
| CN-111936457-B | Enol ether pro-fragrances | 弗门尼舍有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-118295208-A | Chemical amplification type photoresist and preparation method and application thereof | 万华化学集团股份有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20230257678-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2023-08-17 | — | — | US | disclosed |
| EP-3746420-B1 | ENOL ETHER PROPERFUME | FIRMENICH & CIE (CH) | 2023-08-16 | — | — | EP | disclosed |
| US-11667869-B2 | Enol ether pro perfume | FIRMENICH SA (CH) | 2023-06-06 | — | — | US | disclosed |
| EP-1320785-A2 | OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS | Ciba SC Holding AG (CH) | 2003-06-25 | — | — | EP | disclosed |
| WO-2002098870-A1 | SUBSTITUTED OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-12-12 | — | — | WO | disclosed |
| WO-2002046507-A2 | ONIUM SALTS AND THE USE THEROF AS LATENT ACIDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-06-13 | — | — | WO | disclosed |
| WO-2002025376-A2 | OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-03-28 | — | — | WO | disclosed |
| US-20020015906-A1 | Polymer for photoresist, method of production thereof and photoresist composition containing polymer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2002-02-07 | — | — | US | disclosed |
| US-6261738-B1 | LATENT CURING CATALYSTS FOR PHOTORESISTS SUCH AS 2,2,2-TRIFLUORO-1-PHENYL-ETHANONE OXIME-O-METHYL SULFONATE | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667869-B2 | Enol ether pro perfume | CYP2E1, ACADM, PEF1 | HSP90AA1 3895/4885MAPK1 2622/4885SMN1; SMN2 3675/4885 |
| US-20230257678-A1 | ENOL ETHER PROPERFUME | CYP2E1, ADH5, ECI1 | HSP90AA1 3982/4885MAPK1 1918/4885SMN1; SMN2 4277/4885 |
| US-20210115354-A1 | ENOL ETHER PROPERFUME | CYP2E1, ACADM, ALDH5A1 | HSP90AA1 3674/4885MAPK1 3116/4885SMN1; SMN2 3486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.